Publications by authors named "Maya Pai"

Objectives: Since 2020, the Food and Drug Administration has approved multiple extensions to the use of the levonorgestrel (LNG) 52-mg intrauterine device (IUD) for pregnancy prevention beyond 5 years. The accessibility of this information to patients calling a reproductive health clinic to schedule replacement remains unknown. We assess the patient experience in accessing information via phone call on the duration of pregnancy prevention for LNG 52-mg IUD.

View Article and Find Full Text PDF

Objectives: To assess if patients can access extended use of the contraceptive implant when they call to schedule a removal or replacement.

Study Design: We conducted a national secret-shopper study of reproductive clinics with a standardized script. Purposeful sampling provided geographic and practice type diversity.

View Article and Find Full Text PDF